FDOPA PET–guided radiation planning for glioblastoma patients
Part of Cancer clinical trials.
This Phase 2 trial tests a radiation “planning” approach guided by an FDOPA PET scan. It aims to better target glioblastoma tissue in people who can’t follow the standard STUPP treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glioblastoma confirmed by pathology (biopsy or surgery tissue test).
- You are not able to take the standard STUPP radiation/therapy plan (you are considered “unfit”).
- You can have an FDOPA PET scan and it shows increased uptake (the scan lights up enough).
- You can safely have MRI and PET (no MRI/PET contraindications, like certain implants or severe inability to lie still).
- Your scan and planning must allow a safe target: radiation targets cannot be too close to the optic nerves/chiasm (less than 2 cm).
- Your situation fits one of the age/condition groups (adult ranges, performance score like Karnofsky, and biopsy/partial resection details).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This Phase 2 study tests whether a special brain scan called PET-DOPA can help guide repeat radiation for glioblastoma that has come back. It aims to improve treatment planning while keeping tumors within safe radiation limits near important brain structures.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
This Phase 2 study tests a personalized, computer-guided way to plan proton beam radiation for adults with low-grade glioma. The goal is to see if the approach is feasible and can improve how treatment is planned.
This trial uses a special type of PET scan (FET-PET) to help doctors distinguish between pseudoprogression (a temporary reaction to treatment that can look like tumor growth on MRI) and actual tumor recurrence in people with glioblastoma. The goal is to improve management decisions and avoid unnecessary treatments.
This trial tests whether a special PET scan combined with MRI can help guide surgery for glioblastoma. It is for people with a newly diagnosed, single tumor who are candidates for surgery.
Hear when a new Glioblastoma Multiforme, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.